Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04471727
Title Study in Patients With Advanced Cancers Associated With Expression of DLL3 Who Have Failed Standard Available Therapy
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Harpoon Therapeutics

lung small cell carcinoma

Advanced Solid Tumor

neuroendocrine tumor



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.